Researchers Find Genetic Target for Deadly Lymphoma Subtype

Richard I. Fisher, M.D., director of the James P. Wilmot Cancer Center at the University of Rochester Medical Center, has co-authored a study in which scientists have discovered a new gene mutation that drives activated B cell lymphoma.

Read more about the discovery »

News and Notes

Learn about what's going on at the Wilmot Cancer Center

Read more»


Wilmot Cancer Center Calendar of Events